Batch Traceability Dynamics 365: A Pharma Manufacturer's Guide

In September 2012, three contaminated lots of an injectable steroid manufactured by the New England Compounding Center triggered a multistate fungal meningitis outbreak.

By the time the investigation closed, the CDC and FDA had confirmed 751 cases and 64 deaths across 20 states - and it took weeks of manual tracing across roughly 75 healthcare facilities to identify exactly which shipments contained the contaminated lots. That delay wasn't just a tragedy; it was a traceability failure, and it's the scenario that keeps quality and operations leaders awake at night.

Now scale that anxiety down to the everyday reality of a mid-sized pharma manufacturer: a supplier flags a contaminated raw material lot on a Friday afternoon. Can your team tell you, in minutes, exactly which finished batches used that ingredient, which distributors received them, and which pharmacies or hospitals have that stock on their shelves right now?

For too many manufacturers, the honest answer is "give us a few days." In an industry where every hour of delay compounds risk to patients, brand reputation, and regulatory standing, a few days is a few days too many.

This is where Batch traceability Dynamics 365 Business Central capabilities change the equation - turning a scramble through spreadsheets, paper logs, and disconnected systems into a query that returns answers in seconds.

The Problem: Why Batch Traceability Breaks Down in Pharma Manufacturing

Pharmaceutical manufacturing runs on batches - raw materials are combined, processed, and packaged in discrete lots that must be tracked from the moment they arrive on the dock to the moment they reach a patient. On paper, this sounds straightforward. In practice, it's one of the most operationally fragile parts of the business, for a few consistent reasons.

1. Data lives in too many disconnected places

Many manufacturers still run production on the shop floor, inventory in a warehouse management tool, and finance in a separate ERP with quality records sitting in spreadsheets or a standalone LIMS. When a recall investigation starts, someone has to manually stitch these systems together. Traceability in pharma is not a "nice-to-have" but a legal requirement, defined by standards such as GMP, GDP, and the EU Falsified Medicines Directive yet without a unified system, meeting that requirement becomes a manual, error-prone exercise every single time.

2. Recalls are more frequent and more severe than most teams expect

The scale of the problem is bigger than most operations leaders assume. The FDA has issued over 15,351 drug recalls in the U.S. since 2012, and the trend isn't improving. Since 2020, Class I medical device and pharmaceutical recalls - the most serious safety-risk category - have risen 172%, and in 2024 they accounted for over 11% of all recalls. These aren't abstract industry statistics; each one represents a manufacturer that had to answer, under regulatory and public scrutiny, exactly where every unit of an affected lot ended up.

3. The Financial Exposure is Enormous

Recalls don't just cost money on the product itself. A widely cited industry cost breakdown originally published in 2012 and still referenced in current industry analyses found that roughly 35% of total pharmaceutical recall cost is the direct recall operation, while 49% comes from business interruption and 16% from product rehabilitation, communications, and consulting.

In other words, the number that shows up in a board presentation is typically less than half the real bill. More recent data points support the same pattern: a Grocery Manufacturers Association study found that 52% of companies with a major recall reported total financial impact exceeding $10 million, and for roughly 1 in 20 companies that impact exceeded $100 million.

In the closely related medical device sector, McKinsey has estimated that non-routine quality events - recalls, warning letters, and consent decrees, along with associated warranties and lawsuits - cost the industry between $2.5 billion and $5 billion per year. Across every one of these sources, business interruption  halted lines, paused shipments, frozen inventory while an investigation runs - is consistently the largest single line item, and it's also the cost most directly reduced by faster, more accurate traceability.

4. Manual tracking can't keep pace with regulatory demands

Regulations are only getting stricter about traceability granularity. Under the U.S. Drug Supply Chain Security Act (DSCSA), the FDA requires an interoperable, electronic system for identifying and tracing prescription drugs at the package level as they move through the supply chain, including serialization with a unique product identifier and electronic exchange of transaction information between trading partners.

The EU's Falsified Medicines Directive imposes a comparable unit-level serialization and verification requirement across the European market. Both frameworks are built around the same principle: manufacturers must be able to answer, quickly and precisely, where a given batch or unit came from and where it went. Spreadsheet-based tracking or bolt-on tools that don't talk to the core ERP simply weren't built for that level of granularity or speed - and every manual handoff is another place where an error, a delay, or a missing record can creep in.

The common thread across all four problems: traceability isn't just a quality department issue. It's an operations, finance, and IT issue, because a slow or incomplete recall investigation touches production schedules, cash flow, supplier contracts, and system architecture all at once.

The Solution: Built-In Batch Traceability in Dynamics 365 Business Central

This is where Dynamics 365 Business Central earns its place as more than a generic ERP for pharma manufacturers. Rather than bolting traceability onto finance and inventory modules as an afterthought, Business Central treats item tracking - its native term for lot and serial number tracking - as a core part of how inventory moves through the system.

End-to-End Batch Traceability in Dynamics 365 Business Central

Business Central allows manufacturers to track serial numbers and lot numbers of products as they come in the door, through the assembly and manufacturing process, and as the item ships out of the facility. That means a single lot number can be followed from a specific raw material purchase order, through the production BOM that consumed it, into every finished batch it touched, and out to every customer shipment - all inside one system of record.

A few capabilities make this particularly relevant for pharma operations:

• Full lot and serial genealogy. Lot control lets a manufacturer trace the source and destination of specific batches and is required in item tracking codes that define exactly which transactions need a lot of numbers. This means quality teams can set stricter tracking rules on high-risk items (like APIs or controlled substances) and lighter rules on low-risk packaging materials, rather than applying a one-size-fits-all policy.

  
  

• Two-way item tracing. Using Business Central's item tracing function, a user can enter a lot number, run a trace, and see everything that happened to that lot - including which purchase order it came in on and which sales orders it went out on. During a live recall, this single screen replaces what used to be hours of cross-referencing multiple reports.

  
  

• Expiration and warranty date tracking. Warranty and expiration dates can be tracked directly in the base functionality, so shelf-life management and first-expired-first-out (FEFO) picking logic are built into daily warehouse operations, not maintained on the side.

  
  

• Enforced tracking at every transaction point. If an item tracking code requires a lot number and it hasn't been assigned, Business Central stops the posting with an error, whether that's on a sales order, transfer order, or shipment. This closes the gap where a lot number gets missed at the point of shipping - a common cause of broken traceability chains.

  
  

• Auditable documentation at the lot level. Item tracking comments let teams attach dated notes to a specific lot or serial number card - for example, to document a quality assurance check - using a dedicated table that's easy to reference during an audit.

  
  

• Barcode and label support for the shop floor. The system supports printing labels with barcodes tied to items, containers, or lots, so any box, barrel, or container can be scanned and tracked throughout production, warehouse, and distribution reducing the manual data entry errors that plague paper-based tracking.

  
  

Because all of this sits inside the same platform that runs procurement, production, inventory, and finance, a lot number isn't just a warehouse label - it's connected to the purchase price paid for the raw material, the production order that consumed it, and the invoice sent to the customer who received it. That connectivity is what turns traceability from a compliance checkbox into an operational and financial asset.

Why Batch Traceability in Dynamics 365 Business Central Matters in Practice

Consider a mid-sized generics manufacturer that receives notice from a supplier that a specific lot of an active ingredient may be contaminated.

Without integrated batch traceability: The quality team pulls paper receiving logs to identify which purchase orders used that ingredient lot. Production supervisors are asked to manually check work orders for the affected date range. Warehouse staff search physical pallet tags to find which finished goods lots might be affected. Customer service cross-references sales invoices against a separate spreadsheet to figure out which distributors received shipments. This process, spread across four departments and multiple systems, can easily take several days - during which affected product may still be in circulation.

With batch traceability in Business Central: A quality manager enters the supplier's lot number into the item tracing function. Within seconds, the system returns every purchase, production consumption, and sales transaction connected to that lot - including exact quantities, dates, and customer destinations. A targeted hold or recall notice can go out the same day, to only the customers who actually received affected product, rather than a broader precautionary recall that unnecessarily disrupts supply to unaffected accounts.

The difference isn't hypothetical. Given that business interruption alone accounts for roughly 49% of total pharmaceutical recall costs, shaving days off an investigation and narrowing the scope of a recall to only genuinely affected lots has a direct, measurable impact on the bottom line. It also has a direct impact on patient safety, which is the outcome that matters most.

Regulatory requirements like DSCSA and the EU Falsified Medicines Directive will keep raising the bar for how precisely pharma manufacturers must track their products. But compliance is really just the floor. The organizations that treat batch traceability as a genuine operational capability - not a paperwork exercise are the ones that respond to a contamination alert in hours instead of days, contain a recall to the lots that are actually affected, and protect both patient safety and brand trust when it matters most.

Dynamics 365 Business Central's native item tracking gives pharma manufacturers a foundation for exactly that: a single system where every lot, from raw material receipt to final shipment, is connected, searchable, and audit ready. The question worth asking isn't whether your business will face a recall or an audit - in an industry with this much regulatory scrutiny; it's a matter of when. The real question is how fast, and how confidently, your team can respond when it happens.

Get in touch with our team for a walkthrough of how Dynamics 365 Business Central can be configured for your specific manufacturing environment and find out exactly where your current traceability gaps are before your next audit or recall does.